AVH.AX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 02:10):

Stats
Today's Volume	281 858
Average Volume	259 024
Market Cap	355.81M
EPS	$-0.0823 ( 2023-06-30 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.44
ATR14	$0.00200 (0.07%)

Volume Correlation

Long: 0.27 (neutral)

Short: -0.15 (neutral)

Signal:(44.016) Neutral

AVITA Medical, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

AVITA Medical, Inc. Correlation - Currency/Commodity

-0.31
( neutral )

-0.48
( neutral )

0.00
( neutral )

-0.28
( neutral )

AVITA Medical, Inc. Financials

Annual	2022
Revenue:	$34.42M
Gross Profit:	$28.38M (82.45 %)
EPS:	$-0.210

Q3	2023
Revenue:	$13.65M
Gross Profit:	$11.53M (84.51 %)
EPS:	$-0.0686

Q2	2023
Revenue:	$11.75M
Gross Profit:	$9.55M (81.25 %)
EPS:	$-0.0823

Q1	2023
Revenue:	$10.55M
Gross Profit:	$8.88M (84.20 %)
EPS:	$-0.0732

Financial Reports:

No articles found.

AVITA Medical, Inc.

AVITA Medical, Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's skin to use in the treatment of acute thermal burns in patients eighteen years and older. AVITA Medical, Inc. has a research agreement with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical, Inc. in December 2020. AVITA Medical, Inc. was incorporated in 2000 and is based in Valencia, California.